Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Overlooked Blue-Chip Stocks to Buy for Eagle-Eyed Investors

By Josh Enomoto, InvestorPlace Contributor

While the excitement in the market remains centered on meme trades, these overlooked blue-chip stocks offer much-needed stability.

You Must Ask the Obvious Question With Koss Corporation

By Josh Enomoto, InvestorPlace Contributor

While KOSS stock might seem an attractive speculation based on social media, you’ve got to recognize the obvious warning sign.

Zomedica Stock Has More Headwinds Than the Rest of the Pet Industry

By Josh Enomoto, InvestorPlace Contributor

On paper, ZOM stock seems like a no-brainer due to enthusiasm for pet ownership but dig deeper and you’ll find less promising data.

3 Pros, 3 Cons of Ideanomics’ Electric Tractor Argument

By Josh Enomoto, InvestorPlace Contributor

While IDEX stock doesn’t lack for popularity, prospective buyers should perform their due diligence on Ideanomics before making a move.

TPG Pace Beneficial Finance Is Getting Riskier

By Josh Enomoto, InvestorPlace Contributor

Though TPGY stock seems compelling on the narrative front, when you look at the bigger picture, some troubles are brewing.

Churchill Capital’s Premium Is Rich But It’s Not Crazy

By Josh Enomoto, InvestorPlace Contributor

While CCIV stock, which will eventually become Lucid Motors’ equity unit, seems outrageously rich, there’s some credibility here.

Invesco Mortgage Capital Stock May Get Reddit Help, but Don’t Count on It

By Josh Enomoto, InvestorPlace Contributor

IVR stock is now on the radar of the Reddit army but this time, they’re moving against extremely powerful economic undercurrents.

Assess Biotech Landscape Hazards Before Trading Orphazyme Stock

By Josh Enomoto, InvestorPlace Contributor

ORPH stock, a play on Niemann-Pick disease, generated big headlines for its even bigger price action. But you want to do some serious due diligence before gambling on this biotech stock.

7 Fun Stocks to Buy to Introduce Your Kids to the Stock Market

By Josh Enomoto, InvestorPlace Contributor

With the market encountering a bit of a lull, now is a great time to talk to your kids about the importance of stocks to buy.

Buying Into Tilray Stock as a Meme Play Will Benefit the Wrong Side

By Josh Enomoto, InvestorPlace Contributor

While TLRY stock has now drawn attention from the Reddit crowd, insider selling makes banking on social media a tough proposition.

Load More